Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer

Por Wang, Lin-run, Liu, Jian, Huang, Ming-zhu, Xu, Nong
Publicado em 2007

XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies

Por Chen, Jian, Zhao, Qing-wei, Shi, Gen-ming, Wang, Lin-run
Publicado em 2012

The role of quality control circles in sustained improvement of medical quality

Por Wang, Lin-run, Wang, Yang, Lou, Yan, Li, Ying, Zhang, Xing-guo
Publicado em 2013

First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients

Por Li, Ying, Wang, Lin Run, Chen, Jian, Lou, Yan, Zhang, Guo Bing
Publicado em 2014

Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer

Por Wang, Lin-run, Huang, Ming-zhu, Xu, Nong, Shentu, Jian-zhong, Liu, Jian, Cai, Jie
Publicado em 2005

RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum

Por Wang, Lin-run, Zhang, Guo-bing, Chen, Jian, Li, Jun, Li, Ming-wei, Xu, Nong, Wang, Yang, Shentu, Jian-zhong
Publicado em 2011